Sulantrix Ltd

Biotechnology spin-out searching for the next drugs for human diseases. We are drugging pseudokinases, kinases and other enzymes

[Milner Therapeutics Institute @TheMilnerInst]

📣 We're delighted to welcome Sulantrix as an Affiliated Company.

Find more on @sulantrix here: https://t.co/rsP5PgJnIe

[Sulantrix Ltd @sulantrix]

@Sharpe_Lab @Co_Biologists Abstract incoming!

[Hayley Sharpe @Sharpe_Lab]

Deadline approaching: Just over a week to submit an abstract. We have speaker spots, prizes and travel grants available. Join us June 9th-13th in Spain. https://t.co/qxMzBuBVuP @Co_Biologists @EMBO

[Hayley Sharpe @Sharpe_Lab]

#embopseudoenzyme in Spain! Just over a month to abstract deadline: https://t.co/qxMzBuBVuP Exciting programme, poster prizes, presentation slots, travel grants, beach! Gracias: @Co_Biologists @BiochemSoc @sulantrix @thermofisher @FIDATechnology @scisignal @EMBO @embojournal

[Sulantrix Ltd @sulantrix]

@sulantrix are delighted to be sponsoring the 2024 EMBO workshop on pseudoenzymes in Spain, June 10th-13th 2024 https://t.co/DS2u6WQknm organised by @pseudokinase @zeqiraj @Sharpe_Lab @EMBO

[LifeScienceAlliance @LSAjournal]

Check out @LSAjournal's newest Author Interview with Michael Clague @LivUniISMIB and find out more about his career and lab’s newest research findings published in LSA. https://t.co/fIw0INytML
Interview Highlights: a 🧵 👇 (1/7)

[Sulantrix Ltd @sulantrix]

@Eva_Caamano @Pseudoenzyme No kidding. They have been superb.

[Inst of Systems, Molecular & Integrative Biology @LivUniISMIB]

Seven A-level Chemistry Students from @RangeHighSch recently joined Dr @jill_madine and Dr Marie Phelan in the @livuniLivSRF for their annual Analytics Day. Read all about their day here: https://t.co/En1DmHEr8j

[CPR Liverpool @c4pr_liv]

Congratulations to Dr Sally Oswald @SallyOsw, who successfully defended her viva! a well-deserved end to a lot of hard work. Thank you to Dr Chamberlain @Palmitoylation and Dr Kenneth @KennethNiall. @ClaireEEyers @LivUniISMIB

[Sulantrix Ltd @sulantrix]

@SallyOsw @Pseudoenzyme @c4pr_liv Correct answer. Prize is in the post.

[Sulantrix Ltd @sulantrix]

@sulantrix are putting all the ingredients together to create something special.

[Sulantrix Ltd @sulantrix]

#NewProfilePic

[Sulantrix Ltd @sulantrix]

Also excited to reveal our expert SAB, who will help guide the company, including @Keeshanlab @zeqiraj @DrSimonCook1 @kannanlab

[Sulantrix Ltd @sulantrix]

Exciting company update. Our new website: https://t.co/lX24ZTAFrV is up and running. Come meet our scientists and Scientific Advisory Board

[Prof Patrick Eyers @Pseudoenzyme]

@sulantrix are delighted to announce their new website. Come check us out https://t.co/vXhr01aE9X

[Sulantrix Ltd @sulantrix]

Great to see the official @sulantrix link up from our @LivUniISMIB @livuniHLS launch.
https://t.co/4YzvaTwL2X

[Sulantrix Ltd @sulantrix]

New preprint looking at the mysterious human pseudokinase PSKH2 from @kannanlab and @Pseudoenzyme just released.
Evolutionary and cellular analysis of the dark pseudokinase PSKH2 https://t.co/cQSgpooliT

[Biochemical Journal @Biochem_Journal]

New #OpenAccess research: Differential regulation of the pairs of 14-3-3-binding phosphosites on PAK4, PAK5 and PAK6, which comprise a family of ohnologues. https://t.co/Me9rdhAmWS

[Sulantrix Ltd @sulantrix]

Big news from @bmsnews as the first targeted #pseudokinase allosteric drug receives approval for plaque psoriasis @Pseudoenzyme @sulantrix